Hi all,
I still believe they will achieve at least 6 PR for the interim result, which would be an excellent outcome.
One have to considered that Today there is near to zero treatment being able to manage an extension of life expectancy for a patient diagnosed with a Stage 4 Pancreatic cancer. Any progress in that direction is a huge step forward for the science, the patient and his family.
I am looking forward to some panic selling next week to increase my holding.
All the best
- Forums
- ASX - By Stock
- ATX
- Ann: Fifth Confirmed Response in ACCENT Trial
Ann: Fifth Confirmed Response in ACCENT Trial, page-49
Featured News
Add ATX (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
-0.001(1.00%) |
Mkt cap ! $35.46M |
Open | High | Low | Value | Volume |
10.0¢ | 10.5¢ | 9.9¢ | $10.44K | 103.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 892472 | 9.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 1013626 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 892472 | 0.099 |
3 | 160102 | 0.098 |
2 | 249000 | 0.097 |
1 | 52610 | 0.095 |
3 | 299928 | 0.094 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 1013626 | 2 |
0.105 | 457538 | 6 |
0.110 | 784297 | 5 |
0.115 | 139012 | 2 |
0.120 | 44254 | 2 |
Last trade - 10.30am 13/11/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online